Colgate-Palmolive Reports Tomorrow Morning After Rescheduling to Avoid Something More Important

Colgate-Palmolive Company reports first-quarter 2026 earnings before the market opens on May 1, with Wall Street expecting continued momentum from the consumer products giant's innovation-driven growth strategy. The central question is whether management can sustain its four-quarter streak of earnings beats while navigating persistent raw material cost pressures and intensifying promotional activity across key categories. With shares trading near six-month highs and the options market pricing a modest post-earnings move, investors will scrutinize both the quarterly results and forward guidance for signs that pricing power and premiumization efforts can offset margin headwinds.

Part 1: Earnings Preview

Colgate-Palmolive Company is a leading global consumer products company specializing in oral care, personal care, home care, and pet nutrition through its Hill's Pet Nutrition segment. The company's portfolio includes iconic brands such as Colgate toothpaste, Palmolive dish soap, and Hill's Science Diet pet food, serving consumers in over 200 countries.

Colgate reports first-quarter 2026 earnings on May 1 before the market opens. The consensus estimate stands at $0.95 per share on expected revenue of $5.20 billion, representing a 5.8% increase from the prior-year quarter. The company most recently reported $0.95 per share for the fourth quarter of 2025, beating estimates by 4.4%. Compared to the same quarter last year when Colgate earned $0.91 per share, the current estimate implies 4.4% year-over-year growth.

Three key themes define this earnings story:

Innovation and Premiumization: Colgate's aggressive push into premium product tiers and science-based innovation remains central to its growth strategy. The company has invested heavily in AI, digital tools, and data analytics to accelerate product development across all price points. The Total franchise and Hill's Pet Nutrition therapeutic offerings exemplify this approach, with management emphasizing that innovation quality and speed have improved significantly. Investors will watch whether these efforts continue translating into market share gains and pricing power.

Hill's Pet Nutrition Resilience: The Hill's segment has demonstrated remarkable strength despite broader pet category softness. Strong innovation, expanded capacity, and improved retail assortment have driven broad-based growth across core segments, with Prescription Diet and therapeutic products leading the way. The segment's ability to gain share in strategic growth areas like cat food, wet food, and prescription diets will be critical to overall company performance.

Margin Pressure and Cost Management: Rising raw material and packaging costs continue pressuring gross margins, while SG&A expense deleverage has been a persistent headwind. Management faces the challenge of balancing investment in innovation and capacity expansion against near-term margin compression. Weak volumes, macroeconomic uncertainty, and intensifying promotional activity could further constrain pricing power, making cost discipline essential to maintaining profitability targets.

Analysts from Zacks Investment Research note that while Colgate's focus on innovation, premiumization, and digital transformation appears encouraging, the company faces near-term pressure from weak volumes and rising promotional intensity. The consensus view suggests solid consumer demand for personal care and hygiene products should support top-line growth, but margin expansion may prove challenging given the cost environment.

Part 2: Historical Earnings Performance

Colgate has established a remarkably consistent pattern of exceeding Wall Street expectations, beating consensus estimates in all four of the most recent quarters. The magnitude of these beats has been meaningful, ranging from 2.25% to 5.81%, with an average surprise of approximately 3.96%.

The trend shows particular strength in the most recent quarter, where Colgate reported $0.95 per share against an estimate of $0.91, representing a 4.40% beat. This matched the company's strongest performance from the March 2025 quarter when it delivered a 5.81% surprise. The consistency is notable—even the smallest beat in September 2025 still exceeded expectations by 2.25%.

This four-quarter streak of beats, combined with the improving magnitude of surprises in recent quarters, suggests management has developed effective strategies for navigating the current operating environment. The pattern indicates either conservative guidance, operational execution exceeding expectations, or a combination of both factors working in the company's favor.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Colgate typically reports earnings before the market opens, meaning Day 0 represents the first full trading session where investors react to results, while Day +1 captures follow-through momentum.

Historical price behavior reveals significant volatility around Colgate's earnings releases, with the stock averaging an absolute move of 2.75% on Day 0 and 1.30% on Day +1. The Day 0 range averages 3.26%, indicating substantial intraday volatility as the market digests results.

The most recent earnings release on January 30, 2026 produced the largest reaction in the dataset, with the stock surging 5.92% on Day 0 followed by a 1.77% gain on Day +1, suggesting strong positive momentum after a significant beat. However, the pattern is far from uniform—the prior two quarters (October and August 2025) saw modest Day 0 moves of 0.71% and -0.41% respectively, followed by negative Day +1 action.

The data reveals a tendency for larger moves in the first and fourth quarters, with January 2026, January 2025, and October 2024 all producing Day 0 moves exceeding 4% in absolute terms. Day +1 follow-through has been more muted and directionally mixed, averaging just 1.30% and showing no clear pattern of continuation or reversal. Investors should prepare for potential volatility in the 2.5% to 3.5% range based on historical norms, with the possibility of larger moves if results significantly surprise in either direction.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 2.66% for this earnings release, slightly below the stock's historical average Day 0 move of 2.75% but well within the typical range. This suggests options traders are anticipating a relatively standard reaction, though the 3.26% average Day 0 range indicates potential for intraday volatility exceeding the implied move boundaries.

Part 3: What Analysts Are Saying

Wall Street maintains a constructive view on Colgate-Palmolive heading into earnings, with the consensus rating at 4.00 (Buy) based on 21 analysts covering the stock. The breakdown shows 10 Strong Buy ratings, 3 Moderate Buy ratings, 7 Hold ratings, zero Moderate Sell ratings, and 1 Strong Sell rating, reflecting broad optimism about the company's prospects.

The average price target of $94.68 implies approximately 10.9% upside from the current price of $85.36, with estimates ranging from a low of $75.00 to a high of $105.00. This wide range suggests meaningful disagreement among analysts about the company's valuation, though the concentration of Strong Buy ratings indicates most analysts see significant appreciation potential.

Analyst sentiment has remained unchanged over the past month, with rating counts and the average recommendation holding steady at 4.00. This stability suggests analysts are maintaining their positions ahead of the earnings release rather than making significant adjustments to their outlooks. The lack of recent downgrades or upgrades indicates the Street is waiting for fresh data from the quarterly report before reassessing their views on the stock's trajectory.

Part 4: Technical Picture

The Barchart Technical Opinion currently shows a Buy signal at 24%, representing a significant strengthening from last week's Sell signal at 8% but a notable deterioration from last month's Buy signal at 40%. This recent improvement suggests near-term momentum has turned positive, though the signal remains weaker than it was a month ago.

Timeframe Analysis:

• Short-term (Hold): Neutral reading indicates consolidation in the immediate timeframe with no clear directional bias
• Medium-term (50% Buy): Moderate buy signal suggests positive momentum is building in the intermediate timeframe
• Long-term (50% Buy): Moderate buy signal reflects constructive positioning in the longer-term trend structure

Trend Characteristics: The trend is characterized as Weak and Weakening, suggesting the recent improvement in the technical signal lacks conviction and the overall momentum environment remains fragile heading into the earnings release.

From a moving average perspective, Colgate trades above its 5-day ($84.87), 10-day ($84.16), 20-day ($84.28), and 200-day ($83.87) moving averages, but remains below its 50-day ($88.15) and 100-day ($86.23) averages. This mixed picture indicates the stock has stabilized after recent weakness but has yet to reclaim key intermediate-term support levels. The current price of $85.36 sits in a technical no-man's land—above long-term support but below the 50-day average that has acted as resistance. The setup is neither strongly supportive nor particularly cautionary for earnings, with the stock positioned to break out above $88.15 on strong results or potentially retest the $83-84 support zone on disappointment. The weakening trend characteristics suggest limited momentum cushion heading into the release, making the actual results and guidance more critical than usual for determining the post-earnings direction.